Target Price | $379.93 |
Price | $335.71 |
Potential | 13.17% |
Number of Estimates | 36 |
36 Analysts have issued a price target Visa 2026 . The average Visa target price is $379.93. This is 13.17% higher than the current stock price. The highest price target is $410.00 22.13% , the lowest is $300.00 10.64% . | |
A rating was issued by 44 analysts: 33 Analysts recommend Visa to buy, 9 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Visa stock has an average upside potential 2026 of 13.17% . Most analysts recommend the Visa stock at Purchase. |
35 Analysts have issued a sales forecast Visa 2025 . The average Visa sales estimate is $39.5b . This is 7.38% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $40.0b 8.80% , the lowest is $38.6b 5.00% .
This results in the following potential growth metrics:
2024 | $35.9b | 10.02% |
---|---|---|
2025 | $39.5b | 10.00% |
2026 | $43.5b | 10.12% |
2027 | $47.8b | 9.83% |
2028 | $52.0b | 8.83% |
28 Analysts have issued an Visa EBITDA forecast 2025. The average Visa EBITDA estimate is $27.9b . This is 8.15% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $28.9b 12.25% , the lowest is $27.1b 5.28% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $25.2b | 9.73% |
---|---|---|
2025 | $27.9b | 10.59% |
2026 | $30.8b | 10.50% |
2027 | $33.9b | 10.10% |
2028 | $36.6b | 8.05% |
2024 | 70.13% | 0.26% |
---|---|---|
2025 | 70.51% | 0.54% |
2026 | 70.75% | 0.34% |
2027 | 70.93% | 0.25% |
2028 | 70.42% | 0.72% |
24 Visa Analysts have issued a net profit forecast 2025. The average Visa net profit estimate is $21.7b . This is 13.40% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $22.2b 16.24% , the lowest is $20.6b 7.71% .
This results in the following potential growth metrics and future Net Margins:
2024 | $18.7b | 17.67% |
---|---|---|
2025 | $21.7b | 15.77% |
2026 | $24.7b | 14.03% |
2027 | $27.9b | 12.70% |
2028 | $30.7b | 9.95% |
2024 | 52.19% | 6.95% |
---|---|---|
2025 | 54.92% | 5.24% |
2026 | 56.87% | 3.55% |
2027 | 58.36% | 2.62% |
2028 | 58.96% | 1.03% |
24 Analysts have issued a Visa forecast for earnings per share. The average Visa EPS is $11.10 . This is 13.38% higher than earnings per share in the financial year 2024. The highest EPS forecast is $11.38 16.24% , the lowest is $10.55 7.76% .
This results in the following potential growth metrics and future valuations:
2024 | $9.59 | 17.67% |
---|---|---|
2025 | $11.10 | 15.75% |
2026 | $12.66 | 14.05% |
2027 | $14.27 | 12.72% |
2028 | $15.69 | 9.95% |
Current | 34.29 | 8.72% |
---|---|---|
2025 | 30.24 | 11.81% |
2026 | 26.52 | 12.30% |
2027 | 23.53 | 11.27% |
2028 | 21.40 | 9.05% |
Based on analysts' sales estimates for 2025, the Visa stock is valued at an EV/Sales of 16.67 and an P/S ratio of 16.60 .
This results in the following potential growth metrics and future valuations:
Current | 17.90 | 9.95% |
---|---|---|
2025 | 16.67 | 6.85% |
2026 | 15.14 | 9.19% |
2027 | 13.79 | 8.95% |
2028 | 12.67 | 8.11% |
Current | 17.82 | 9.66% |
---|---|---|
2025 | 16.60 | 6.87% |
2026 | 15.07 | 9.19% |
2027 | 13.72 | 8.95% |
2028 | 12.61 | 8.11% |
Analyst | Rating | Action | Date |
---|---|---|---|
Evercore ISI Group |
➜
In-Line
|
Initiated | Apr 09 2025 |
Susquehanna |
Positive
➜
Positive
|
Unchanged | Feb 21 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Feb 03 2025 |
B of A Securities |
Neutral
➜
Neutral
|
Unchanged | Jan 31 2025 |
Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Jan 31 2025 |
Goldman Sachs |
Buy
➜
Buy
|
Unchanged | Jan 31 2025 |
JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Jan 31 2025 |
Analyst Rating | Date |
---|---|
Initiated
Evercore ISI Group:
➜
In-Line
|
Apr 09 2025 |
Unchanged
Susquehanna:
Positive
➜
Positive
|
Feb 21 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Feb 03 2025 |
Unchanged
B of A Securities:
Neutral
➜
Neutral
|
Jan 31 2025 |
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Jan 31 2025 |
Unchanged
Goldman Sachs:
Buy
➜
Buy
|
Jan 31 2025 |
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Jan 31 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.